PETERSON SCOTT ROBERT

CIK 00015639861 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001563986

Recent Transactions

26 trades

Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−155,500→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−51,200→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−11,300→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−41,667→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−8,334→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−8,334→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−25,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−65,000→ 0 total
Disposition from Tender
Cascadian Therapeutics, Inc.
Common Stock
2018-03-09−3,639→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Restricted Stock Units
2018-03-09−14,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−8,334→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−25,000→ 0 total
Disposition to Issuer
Cascadian Therapeutics, Inc.
Stock Option (Right to buy)
2018-03-09−54,167→ 0 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2018-02-01+155,500→ 155,500 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2018-01-11−2,825→ 8,475 total
Exercise/Conversion
Cascadian Therapeutics, Inc.
Common Stock
2018-01-11+2,825→ 4,562 total
Tax Payment
Cascadian Therapeutics, Inc.
Common Stock
2018-01-11$3.92/sh−923→ 3,639 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2017-09-18+65,000→ 65,000 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-09-18+14,000→ 14,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2017-01-11+51,200→ 51,200 total
Award
Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
2017-01-11+11,300→ 11,300 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2016-05-17+325,000→ 325,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2015-09-24+250,000→ 250,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2014-12-16+150,000→ 150,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2013-12-12+150,000→ 150,000 total
Award
Cascadian Therapeutics, Inc.
Stock Option (right to buy)
2012-12-12+50,000→ 50,000 total

Companies

Cascadian Therapeutics, Inc.
Chief Scientific Officer

Recent Filings

Address

C/O ONCOTHYREON INC. 2601 FOURTH AVENUE, SUITE 500

SEATTLE, WA, 98121

View on SEC.gov